ADGM logo

ADGM
Adagio Medical Holdings Inc.

565
Mkt Cap
$28.43M
Volume
56,208.00
52W High
$2.87
52W Low
$0.74
PE Ratio
-0.77
ADGM Fundamentals
Price
$1.28
Prev Close
$1.41
Open
$1.40
50D MA
$1.07
Beta
0.13
Avg. Volume
59,404.79
EPS (Annual)
-$1.51
P/B
2.29
Rev/Employee
$0.00
$21.89
Loading...
Loading...
News
all
press releases
Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS Ventricular Ablation System
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to...
Business Wire·4d ago
News Placeholder
More News
News Placeholder
Adagio Medical to Participate in the 25th Annual Needham Virtual Conference
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management...
Business Wire·6d ago
News Placeholder
Adagio Medical Ultralow Temperature Ablation U.S. Pivotal Study Results to be Presented in Late-Breaking Session at Heart Rhythm Society 2026
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the pivotal...
Business Wire·11d ago
News Placeholder
Adagio Medical Reports Fourth Quarter and Full Year 2025 Results
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results for the fourth quarter ended December 31, 2025. Fourth Quarter and Recent Business Highlights...
Business Wire·16d ago
News Placeholder
Adagio Medical Announces Publication of Pre-Clinical Results for Next Generation Ventricular Ablation Catheter
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the publication...
Business Wire·19d ago
News Placeholder
Adagio Medical Highlights Recent Successful Expanded Access Cases with vCLAS System, Including Patients with Premature Ventricular Contractions (PVC)
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the successful...
Business Wire·24d ago
News Placeholder
Adagio Medical to Participate in the 38th Annual Roth Conference
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management...
Business Wire·1mo ago
News Placeholder
Adagio Medical to Participate in the TD Cowen 46th Annual Healthcare Conference
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management...
Business Wire·2mo ago
News Placeholder
Adagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial Readiness
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced two key additions...
Business Wire·4mo ago
News Placeholder
Deborah Kaster Purchases 15,000 Shares of Adagio Medical (NASDAQ:ADGM) Stock
Adagio Medical Holdings, Inc. (NASDAQ:ADGM - Get Free Report) CFO Deborah Kaster purchased 15,000 shares of the company's stock in a transaction on Tuesday, December 16th. The stock was purchased at...
MarketBeat·4mo ago
<
1
2
...
>

Latest ADGM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.